Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.46 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.40 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5162276 | 0.78 | TSHR (0.41) | TSHRGABRR1GABRR2BLMLMNA | |
| SCHEMBL28637241 | 0.75 | TSHR (0.42) | TSHRGABRR1GABRR2BLMLMNA | |
| SCHEMBL14801551 | 0.74 | TSHR (0.46) | TSHRGABRR1GABRR2BLMLMNA | |
| SCHEMBL2467206 | 0.74 | TSHR (0.46) | TSHRGABRR1GABRR2BLMLMNA | |
| SCHEMBL455399 | 0.74 | TSHR (0.46) | TSHRGABRR1GABRR2BLMLMNA | |
| SCHEMBL3084517 | 0.74 | TSHR (0.46) | TSHRGABRR1GABRR2BLMLMNA | |
| SCHEMBL3023206 | 0.74 | TSHR (0.46) | TSHRGABRR1GABRR2BLMLMNA | |
| SCHEMBL2467205 | 0.74 | TSHR (0.46) | TSHRGABRR1GABRR2BLMLMNA | |
| SCHEMBL21521060 | 0.74 | TSHR (0.46) | TSHRGABRR1GABRR2BLMLMNA | |
| SCHEMBL3023205 | 0.74 | TSHR (0.46) | TSHRGABRR1GABRR2BLMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3408301-B1 | A PROCESS FOR OBTAINING A CATIONIC POLYMER WITH AN AT LEAST BIMODAL MOLECULAR WEIGHT DISTRIBUTION | BASF SE (DE) | 2020-03-11 | — | — | EP | claimed |
| EP-3408302-B1 | CATIONIC POLYMER WITH AN AT LEAST BIMODAL MOLECULAR WEIGHT DISTRIBUTION | BASF SE (DE) | 2019-11-13 | — | — | EP | claimed |
| EP-3172305-B1 | FABRIC AND HOME CARE TREATMENT COMPOSITIONS | PROCTER & GAMBLE (US) | 2019-04-03 | — | — | EP | claimed |
| EP-3172302-B1 | FABRIC AND HOME CARE TREATMENT COMPOSITIONS | PROCTER & GAMBLE (US) | 2019-01-16 | — | — | EP | claimed |
| EP-3172301-B1 | FABRIC AND HOME CARE TREATMENT COMPOSITIONS | PROCTER & GAMBLE (US) | 2019-01-02 | — | — | EP | claimed |
| EP-3172303-B1 | FABRIC AND HOME CARE TREATMENT COMPOSITIONS | PROCTER & GAMBLE (US) | 2019-01-02 | — | — | EP | claimed |
| EP-3172298-B1 | FABRIC AND HOME CARE TREATMENT COMPOSITIONS | PROCTER & GAMBLE (US) | 2019-01-02 | — | — | EP | claimed |
| EP-0393954-B1 | A radiation-curable organopolysiloxane compound, method for the preparation thereof and method of forming a cured coating film | SHINETSU CHEMICAL CO (JP) | 1994-04-06 | — | — | EP | claimed |
| EP-1904442-A1 | HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007005503-A1 | HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2007-01-11 | — | — | WO | disclosed |
| EP-0819984-B1 | Irradiation-sensitive recording material for flexographic printing plates | DU PONT DEUTSCHLAND (DE) | 2002-05-08 | — | — | EP | disclosed |
| EP-0819984-A1 | Irradiation-sensitive composition and an irradiation-sensitive recording material containing the composition for flexographic printing plates | DU PONT DE NEMOURS (DEUTSCHLAND) GMBH (DE) | 1998-01-21 | — | — | EP | disclosed |